Treatment Registry
TR-0590 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by REMEVi · Injection, vial · every compounded tirzepatide record

What you actually pay

Per month

$319

Medication · Monthly, no commitment$319

Added from the figures recorded below.

Price

TermPer monthCharged today
Monthly, no commitment

Monthly No commitment, cancel anytime $319 /mo $11.39/day

source

Per month$319Charged today$319
12-Week, most popular

12-Week Most popular Total $747 · SAVE $210 $249 /mo $8.89/day

source

Per month$249Charged today$747
24-Week, best price

24-Week Best price Total $1,374 · SAVE $540 $229 /mo $8.18/day

source

Per month$229Charged today$1,374
Visit REMEVi

We earn nothing from this link. REMEVi has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PharmacyRedRock Pharmacy, St. George UT; Health Warehouse, Florence KY; Precision Medicine, Bellmore NY; Triad Rx, Daphne AL
StatesAll 50 states
Cancellation“Can I pause or cancel my prescription? + Yes - you can cancel or pause your program at any time with no cancellation fees. Simply log into your patient portal or contact your care coordinator.”

Not yet checked: prescriber, membership and consult fee.

Recorded from remevihealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026Explicitly no membership fee, repeatedly: 'We sell medicine not memberships' and a comparison table showing '$79-$149/mo Membership fees / What most programs add on top' crossed out to $0. All prices are flat regardless of dose per the site's own claim. The homepage HTML contains an internal marketing/analytics comment about a Google Tag Manager cutover embedded oddly in the page source; this is developer/marketing documentation, not visible reader-facing text, and was not treated as a fact or instruction.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0590
Readings
1

Related records

What else REMEVi sells

All REMEVi programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). REMEVi compounded tirzepatide (TR-0590). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0590

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.